Products

What will AGI do for Amifloxacin?

This classification denotes a quinolone antibiotic with the molecular formula C16H19FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5TU5227KYQ, chemically known as 6-fluoro-1,4-dihydro-1-(methylamino)-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid but generally known as amifloxacin, which bears US NIH Compound Identifier 55492. Amifloxacin most often comes in mesylate and n-oxide forms. European Medicines Agency schedules Amifloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05430MIG. The term AMIFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). AMIFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amifloxacin under HS 29335995 and SITC 51576. As of Q4 2014, AMIFLOXACIN remains the US FDA Preferred Term for this commodity. Amifloxacin bears US NLM identifiers UMLS ID C0051596 and NCI Concept Code C72696. SMILES: FC1C(N2CCN(CC2)C)CC2N(NC)CC(C(=O)C2C1)C(=O)O.

How AGI delivers it

Four ways AGI delivers for Amifloxacin

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amifloxacin, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amifloxacin, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amifloxacin connects

measured by

  • Assay Puritymodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Residual Solventmodel